A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies
Constellation Pharmaceuticals
Constellation Pharmaceuticals
Ohio State University Comprehensive Cancer Center
Novartis
Mayo Clinic
Italfarmaco
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Traws Pharma, Inc.
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Asan Medical Center
S*BIO
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center